How many patents does
Supernus Pharmaceuticals have?
patents
428
families
40
granted
125
applications
303
US
134
EP
73
JP
38
WO
22
CN
8
KR
3
RoW
150
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Supernus Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
| supernus pharmaceuticals | 358 |
| shire laboratories | 15 |
| tcd royalty sub | 4 |
| united therapeutics corporation | 1 |
| supermus pharmaceuticals | 1 |
2009
| supernus pharmaceuticals | 42 |
| shire laboratories | 3 |
Supernus Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| controlled released preparations of oxcarbazepine having sigmoidal release profile | 35 | 2006 |
| methods for producing viloxazine salts and novel polymorphs thereof | 28 | 2010 |
| sustained-release formulations of topiramate | 28 | 2006 |
| once daily formulations of tetracyclines | 27 | 2003 |
| method of treatment of aggression | 25 | 2008 |
| methods of producing molindone and its salts | 25 | 2012 |
| once daily dosage forms of trospium | 25 | 2003 |
| osmotic drug delivery system comprising release enhancing agent | 23 | 2006 |
| stabilized formulations of cns compounds | 18 | 2010 |
| modified release formulations of viloxazine | 18 | 2012 |